Company: KNRX
Filing Date: 2025-08-21
Form Type: F-1/A
Source: 0001641172-25-025066
Chunk: 177

Company: KNOREX LTD.
Filing Date: 2025-08-21
Form: F-1/A
Chunk 177
---
 offering (including the over-allotment shares). We and the Representative will cooperate in obtaining the necessary approvals and qualifications in such states as the Representative deems necessary and/or desirable.

The foregoing does not purport to be a complete statement of the terms and conditions of the underwriting agreement and subscription agreement. A form of the underwriting agreement will be included as an exhibit to the registration statement of which this prospectus forms a part.

| 93 |

Right of First Refusal

If within the 18-month period following consummation of this offering, we or any of our subsidiaries (i) decides to finance or refinance any indebtedness using a manager or agent, the Representative (or any affiliate designated by the Representative) shall have the right to act as sole investment banker, sole book-runner, sole placement agent and/or sole advisor, at the Representative’s sole discretion, with respect to such financing or refinancing; or (ii) decides to raise funds by means of an equity offering or a private placement of equity or debt securities using an underwriter or placement agent, the Representative (or any affiliate designated by the Representative) shall have the right to act as exclusive financial advisor, sole investment banker, sole book-runner and/or sole placement agent, at the Representative’s sole discretion, for such financing. Such right of first refusal shall be subject to FINRA Rule 5110(g)(5).

Tail Financing

During the twelve (12)-month period following the completion of the offering, in the event that the Company receives proceeds from the sale of the equity, debt and/or equity derivative instruments from any investor actually introduced by the Representative, the Representative shall be entitled to a cash fee equal to seven and a half percent (7.5%) of the gross proceeds received by the Company; provided, that pursuant to FINRA Rule 5110(g)(5), the Company retains the right to terminate the engagement with the Representative “for cause”, which means the Representative’s material failure to provide the underwriting services, and any such termination will eliminate any obligation of the Company to pay any cash fee pursuant to this paragraph.

Listing

We intend to apply to list our Class A Ordinary Shares on the NYSE American Market under the symbol KNRX. We make no representation that such application will be approved or that our Class A Ordinary Shares will trade on such market either now or at any time in the future. However, we will not complete this offering unless we are so listed.

Indemnification

We have agreed to indemnify the underwriters